Solutions by Therapeutic Area
Gastrointestinal Diseases
We offer optimized non-clinical testing services for gastrointestinal and liver disease research. This includes acute and chronic liver diseases (MASH, MAFLD, acute liver injury) and models for inflammatory bowel disease (IBD) and gastrointestinal disorders, providing reliable data. Our GLP-compliant study designs and customized research approaches support the development of gastrointestinal disease treatments, ensuring clients achieve their research objectives efficiently.
Gastrointestinal Diseases FAQ
Are biopsy-confirmed MASH models available?
Yes, we utilize models such as MCD, CDHF, and biopsy-confirmed DIO NASH models. Our in-house pathology experts are directly involved in experiments to assess disease progression with precision and optimize study designs.
What data is provided in IBD models?
- Clinical Scores: Evaluation of symptoms like weight loss, diarrhea, and bloody stools
- Histopathological Analysis: Assessment of mucosal damage and inflammation
- Cytokine Analysis: Measurement of inflammatory mediators such as IL-6 and TNF-α